MediPharm Labs Corp. (MEDIF) Financials
MEDIF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 32.4 million | 7.4 million |
| March 31, 2026 | 31.4 million | 6.1 million |
| Dec. 31, 2025 | 33.3 million | 7.2 million |
| Sept. 30, 2025 | 33.5 million | 6.3 million |
MEDIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -311230 | ? |
| March 31, 2026 | -560080 | 110436 |
| Dec. 31, 2025 | 346183 | 153903 |
| Sept. 30, 2025 | -124962 | 139325 |
MEDIF Net Income
No data available :(
MEDIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 6.9 million | - | - |
| March 31, 2026 | 7.1 million | - | 12908 |
| Dec. 31, 2025 | 7.9 million | - | 37199 |
| Sept. 30, 2025 | 7.6 million | - | 51708 |
MEDIF Shares Outstanding
MEDIF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 32389 | 58443 | 3.1 million | - |
| March 31, 2026 | 717 | 17254 | 3.1 million | 930822 |
| Dec. 31, 2025 | - | 37897 | 3.7 million | -630933 |
| Sept. 30, 2025 | 11490 | 33754 | 3.2 million | 829491 |
MEDIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 7.0 million | 4.0 million |
| March 31, 2026 | 6.4 million | 3.9 million |
| Dec. 31, 2025 | 8.1 million | 5.3 million |
| Sept. 30, 2025 | 8.2 million | 6.4 million |
MEDIF
Price: $0.05
52 week price:
Earnings Per Share: -0.03 USD
P/E Ratio: -1.83
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 22.5 million